R2 Surgical Announced as 2026 Industry Awards Finalist

We are thrilled to announce that R2 Surgical has been selected as a finalist for the 2026 Surgical Robotics Industry Awards, sponsored by Surgical Robotics Technology.

This marks the third consecutive year the company has achieved this honor, demonstrating our continued commitment to innovation and excellence in the field of surgical robotics.

A Celebration of Innovation and Leadership

The Surgical Robotics Industry Awards celebrate the significant contributions of individuals, organizations, and technologies that are shaping the future of surgery. This year's awards have again drawn an impressive array of nominees, and we send our congratulations to all of the other finalists:

AiM Medical Robotics, Andromeda Surgical, LITLaboratories , Inc., Lupin Dental, Microbot Medical, Nami Surgical , Nanoflex Robotics , Robeauté, and Swan EndoSurgical Inc.

Nomination Categories and Criteria

R2 Surgical has been recognized in the category of Innovative Start-Up, a segment dedicated to companies with fewer than 50 employees or those younger than six years. Nominees in this category are celebrated for their technological or commercial success, innovative solutions that offer substantial benefits, rapid growth, or significant investment, and a strong commitment to ethical values.

Other nomination categories include Industry Leadership, Outstanding Company, Outstanding Healthcare Provider, Software Innovation, and Groundbreaking Technology.

Vote for Innovation

Voting is now open for the 2026 Surgical Robotics Industry Awards. To vote for R2 Surgical, please visit surgicalroboticstechnology.com. Voting closes June 9. Your vote not only supports our mission but also promotes continued innovation in surgical robotics.

Thank You for Your Support

We extend our deepest gratitude to our employees, partners, and supporters who believe in our vision and work tirelessly to advance the boundaries of medical technology. Your continued support inspires us daily and drives our success in this exciting industry.

Our Mission

The surgical robotics landscape continues to evolve at an incredible pace. But innovation alone doesn’t solve the accessibility challenge.

For many hospitals around the world, the cost of adopting and maintaining robotic technology remains a significant barrier.

At R2 Surgical, we’ve seen what removing those barriers can look like.

In Ukraine, robotic surgery programs have been built despite immense unrest in the region. In Nigeria, robotic technology is now helping lower mortality rates for prostate cancer across Western Africa.

Maximizing the impact of surgical robotics will continue to depend not only on innovation, but on access. Creating more affordable and sustainable pathways is key to that effort.